9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
10/24/10	0.000001 $	-90.00%	7,568
09/24/09	0.000010 $	+900.00%	665
06/24/06	0.000001 $	0.00%	616
05/24/05	0.000001 $	0.00%	346
04/24/04	0.000001 $	0.00%	250

Delayed Quote OTC Markets, December 10, 2024 at 11:33 pm IST

More quotes

Income Statement and Estimates

income-statement-evolution-chart 9-METERS-BIOPHARMA-INC

More financial data

Quarterly revenue - Rate of surprise

quality-estimates-chart 9-METERS-BIOPHARMA-INC

Company calendar

Market Closed - OTC Markets Other stock markets 11:33:34 10/12/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-90.00%		+900.00%	+900.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

Capitalization	14 13.3 12.36 10.96 19.84 1.19T 21.95 153.54 56.59 487.96 52.56 51.42 2.13T	P/E ratio 2021	-6.47x	P/E ratio 2022	-0.37x
Enterprise value	70.83L 67.27L 62.52L 55.45L 1Cr 60Cr 1.11Cr 7.77Cr 2.86Cr 25Cr 2.66Cr 2.6Cr 107.59Cr	EV / Sales 2021	-	EV / Sales 2022	-
Free-Float	98.29%	Yield 2021 *	-	Yield 2022	-

North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11	CI
North American Morning Briefing : Stocks Look to -2-	06/11	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11	CI
North American Morning Briefing : Stock Futures -2-	22/23/22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	15/23/15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08/23/08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01/23/01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25/23/25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	18/23/18	DJ
North American Morning Briefing : Stock Futures -2-	11/23/11	DJ

Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	18/23/18	MT
Truist Downgrades 9 Meters Biopharma to Hold From Buy	20/23/20	MT
Citigroup Initiates Coverage on 9 Meters Biopharma With Neutral Rating, $2.70 Price Target	13/23/13	MT
Oppenheimer Adjusts 9 Meters Biopharma Price Target to $51 From $5, Maintains Outperform Rating	02/22/02	MT
Oppenheimer Adjusts Price Target on 9 Meters Biopharma to $5 From $4, Maintains Outperform Rating	27/22/27	MT

9 Meters Biopharma, Inc. Share Price

Equities

NMTRQ

US6544052086

Investment Holding Companies

Valuation: 9 Meters Biopharma, Inc.

Chart: 9 Meters Biopharma, Inc.

Latest news: 9 Meters Biopharma, Inc.

Analysts' recommendations: 9 Meters Biopharma, Inc.

Press Releases: 9 Meters Biopharma, Inc.

Quotes and Performance

Course Extremes

ETFs: 9 Meters Biopharma, Inc.

Shell Companies

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise

Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	02/23/02	AQ
9 METERS BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)	31/23/31	AQ
9 METERS BIOPHARMA, INC. : Other Events (form 8-K)	22/23/22	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Financial Statements and Exhibits (form 8-K)	27/23/27	AQ
9 METERS BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	07/23/07	AQ

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
9 METERS BIOPHARMA, INC.	-90.00%	+900.00%	-	-	144
PERELLA WEINBERG PARTNERS	-2.27%	-4.69%	+102.81%	+93.70%	148.06Cr
APPLE ISPORTS GROUP, INC.	-5.88%	-9.09%	+65.02%	+233.33%	110.76Cr
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-4.86%	+2.04%	91Cr
ARES ACQUISITION CORPORATION II	+0.09%	+0.09%	+5.19%	-	68Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	-.--%	-.--%	+100.00%	60Cr
CAPITOL INVESTMENT CORP. VII	-.--%	-.--%	-	-	50Cr
AEA-BRIDGES IMPACT CORP.	+6.80%	-7.01%	-	-41.02%	47Cr
DONG FANG HUI LE INC.	+12.50%	-.--%	-.--%	-64.00%	45Cr
AGRICULTURE & NATURAL SOLUTIONS ACQUISITION CORPORATION	0.00%	+0.02%	-	-	45Cr
Average	-7.91%	+89.05%	+28.03%	+54.01%	66.56Cr
Weighted average by Cap.	-0.19%	-1.04%	+42.65%	+81.81%

	2021	2022
Net sales	-	-
Net income	-3.68Cr -3.49Cr -3.25Cr -2.88Cr -5.21Cr -312.1Cr -5.77Cr -40Cr -15Cr -128.19Cr -14Cr -14Cr -558.68Cr	-4.38Cr -4.16Cr -3.86Cr -3.43Cr -6.2Cr -371.39Cr -6.86Cr -48Cr -18Cr -152.55Cr -16Cr -16Cr -664.81Cr
Net Debt	-4.68Cr -4.45Cr -4.13Cr -3.67Cr -6.64Cr -397.35Cr -7.34Cr -51Cr -19Cr -163.21Cr -18Cr -17Cr -711.27Cr	70.83L 67.27L 62.52L 55.45L 1Cr 60Cr 1.11Cr 7.77Cr 2.86Cr 25Cr 2.66Cr 2.6Cr 107.59Cr